Israel's grass to grow greener, cabinet about to approve cannabis exports

High times are awaiting Israel’s cannabis and tech sectors, as the cabinet is set to approve legislation allowing the export of medical cannabis.

The bill passed its third reading in the Knesset last month and is pending only the cabinet’s and Prime Minister Benjamin Netanyahu’s confirmation to be signed into law, which is expected to happen on Sunday.

Israel is already considered a world leader in cannabis production, and the legalization of exports will boost the sector even more, allowing Israel to compete in an industry that is expected to reach $33 billion worldwide in the next five years. Tax revenue could rise as much as NIS 1b. through the export permit.


New Israeli-US investment fund for cannabis technology

A $30 million cannabis technology venture capital fund is under establishment by Jerusalem-based global investment platform OurCrowd and the 7thirty Opportunity Fund of Boulder, Colorad

The new fund will invest in emerging companies involved in med-tech, ag-tech, retail, e-commerce, marketplaces, SaaS solutions, and deep-tech research related to cannabis. It will be headquartered in Boulder with activities in Israel, Canada and the United States.


Distribution agreement struck between The Greater Cannabis Company and iCAN: Israel Cannabis Ltd.

The Greater Cannabis Company, Inc. (GCAN) has entered into a letter of intent (LOI) with iCAN Cannabis to expand distribution of GCAN’s eluting patch platform into key global markets.

The LOI calls for including commercial-ready formulations to meet medical and recreational market demands, notes a statement from iCAN: Israel Cannabis, an Israeli developer of cannabis-based formulations, clinical trials and cannabis testing.

“Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, South Africa, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia and Portuguese territories,” the statement adds.


Israel's pro-cannabis party plans to sue Facebook over blocked political ads

Israel's pro-cannabis party Green Leaf (Ale Yarok) are threatening Facebook with a lawsuit after the social media giant took down one of their publicity campaigns, writes Calvin Hughes. 


Israeli legislation paves the way for exporting medical cannabis in 2019

A bill revolving around the governance and regulatory aspects of exporting medical cannabis from Israel passed the Israeli Parliament on Christmas day, a move Seedo Corp. says brings the industry one step closer to finalizing export of medical cannabis.


Israel likely to allow medical cannabis exports

Israel will likely allow exports of medical cannabis by the end of the year, a top lawmaker said on Thursday, a move that would boost state coffers and slow the growing number of firms establishing farms abroad.

Israeli companies - befitting from a favourable climate and expertise in medical and agricultural technologies - are among the world's biggest producers of medical cannabis.

The finance and health ministries estimate exports could bring in about $1 billion a year - but some MPs have up to now stopped Israeli-grown cannabis going abroad, fearing more cultivation could push more drugs onto the streets at home.


Strainprint Technologies partners with Israeli research leaders to study cannabis as a treatment for endometriosis

Cannabis’ ability to treat numerous illnesses and conditions is becoming more apparent by the day in the wake of legalization and this is especially true for a number of conditions specifically affecting women's health.

More and more women are opting to use cannabis to treat symptoms associated with premenstrual syndrome and menopause, but it’s also having very positive outcomes in treating other conditions that affect women in particular.  As such, Strainprint Technologies Ltd. announced last month that it has partnered with Israel-based research groups, Lumir Lab and Gynica to conduct clinical studies on how cannabis can be used to treat endometriosis. The study will be the first of its kind and will be carried out simultaneously in both Canada and Israel.


Edible cannabis honey causes a buzz

Innovative Israeli cannabis technology company PhytoPharma International is causing a buzz! The artisanal honey producing company’s bees are feasting on a spectrum that contains cannabinoids. Since bees are insects that do not have a mammalian endocannabinoid system, they are not getting high. However, they pass these nutrients directly through their natural honey making process and –voila– they create Pure Bee cannabis honey.


Have Canadians given up on Israeli cannabis exports?

DLA Piper Canada partner Adv. Noam Goodman and iCan founder Saul Kaye speak to "Globes" about the cannabis opportunities Israel is missing.

Last month cannabis became completely legal throughout Canada for both medical and leisure purposes. However, although the Canadian market represents a larger than ever opportunity for Israeli companies, the Canadians have already given up somewhat on working with Israel, explains DLA Piper Canada Partner Adv. Noam Goodman, who specializes in cannabis regulation.


Israel and Canada high on budding medical cannabis ties

Israel, the so-called Start-up Nation, could soon become known as the Silicon Valley of medical marijuana if leaders in the industry have their way. Israel’s medical cannabis sector is flourishing, thanks in part to growing business ties with Canada, which recently legalized marijuana.

Hundreds of millions of dollars in deals between Canadian and Israeli companies have already been inked, with investments covering innovative products treating a wide range of health issues—from cancer, to epilepsy, to sleep disorders.

Saul Kaye is the man behind the CannaTech conference—one of the biggest international events in the industry—which takes place each year in Israel.


Subscribe to RSS - Israel